Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial
Authors
Chong, S.Wong, H. Y.
Althabteh, A.
Cox, C.
Stevenson, P.
Brown, S.
Griffin, A.
Isbel, N.
Siller, G.
Soyer, H. P.
Schaider, H.
Roy, E.
Campbell, S.
Green, A. C.
Khosrotehrani, K.
Affiliation
The University of Queensland, UQ Diamantina Institute, Experimental Dermatology Group, Brisbane Australia. The University of Queensland, UQ Diamantina Institute, Experimental Dermatology Group, Brisbane Australia; Princess Alexandra Hospital, Department of Dermatology, Brisbane Australia. Princess Alexandra Hospital, Department of Dermatology, Brisbane Australia. Princess Alexandra Hospital, Department of Nephrology and Transplantation services, Brisbane Australia. Princess Alexandra Hospital, Department of Dermatology, Brisbane Australia; The University of Queensland, UQ Diamantina Institute, Dermatology Research Centre, Brisbane Australia. Princess Alexandra Hospital, Department of Dermatology, Brisbane Australia; The University of Queensland, UQ Diamantina Institute, Dermatology Research Centre, Brisbane Australia; Sunshine Coast Hospital and Health Service, Department of Dermatology, Birtinya, Queensland, Australia. QIMR Berghofer Medical Research Institute, Brisbane, Australia; CRUK Manchester Institute and Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. The University of Queensland, UQ Diamantina Institute, Experimental Dermatology Group, Brisbane Australia; Princess Alexandra Hospital, Department of Dermatology, Brisbane Australia; The University of Queensland, UQ Diamantina Institute, Dermatology Research Centre, Brisbane Australia. Electronic address: k.khosrotehrani@uq.edu.au.Issue Date
2022
Metadata
Show full item recordCitation
Chong S, Wong HY, Althabteh A, Cox C, Stevenson P, Brown S, et al. Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial [Internet]. Journal of the American Academy of Dermatology. Elsevier BV; 2022.Journal
J Am Acad DermatolDOI
10.1016/j.jaad.2022.02.039PubMed ID
35219749Additional Links
https://dx.doi.org/10.1016/j.jaad.2022.02.039Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jaad.2022.02.039
Scopus Count
Collections
Related articles
- A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
- Authors: Dragieva G, Prinz BM, Hafner J, Dummer R, Burg G, Binswanger U, Kempf W
- Issue date: 2004 Jul
- Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
- Authors: Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, Bailey H, Kang S, Linden KG, Heffernan M, Duvic M, Richmond E, Elewski BE, Umar A, Bell W, Gordon GB
- Issue date: 2010 Dec 15
- Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
- Authors: Weinstock MA, Thwin SS, Siegel JA, Marcolivio K, Means AD, Leader NF, Shaw FM, Hogan D, Eilers D, Swetter SM, Chen SC, Jacob SE, Warshaw EM, Stricklin GP, Dellavalle RP, Sidhu-Malik N, Konnikov N, Werth VP, Keri JE, Robinson-Bostom L, Ringer RJ, Lew RA, Ferguson R, DiGiovanna JJ, Huang GD, Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group.
- Issue date: 2018 Feb 1
- Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
- Authors: Beatson M, Siegel JA, Chren MM, Weinstock MA
- Issue date: 2019 Oct 1
- Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
- Authors: Hasan ZU, Ahmed I, Matin RN, Homer V, Lear JT, Ismail F, Whitmarsh T, Green AC, Thomson J, Milligan A, Hogan S, Van-de-Velde V, Mitchell-Worsford L, Kentley J, Bowden S, Gaunt P, Wheatley K, Proby CM, Harwood CA
- Issue date: 2022 Jan 5